BioSpace News Archive

Veracyte Announces New Clinical Utility Data Suggesting Envisia Genomic Classifier Enables as Confident a Diagnosis in IPF as Surgical Pathology

The new data were shared during the Pulmonary Fibrosis Foundation’s biannual PFF Summit, being held November 9-11 in Nashville, Tenn.

November 9, 2017
·
5 min read
Business

Athersys Reports Third Quarter 2017 Results

Management to host conference call at 4:30 pm EST today.

November 9, 2017
·
10 min read
Business

Collegium Reports Third Quarter Financial Results and Provides Corporate Update - Nov. 9, 2017

Net product revenues for Xtampza ER for the 2017 Quarter were $12.0 million ($7.6 million without the one-time $4.4 million increase) compared to $408,000 for the quarter ended September 30, 2016 (the “2016 Quarter”).

November 9, 2017
·
14 min read
Business

MacroGenics Provides Update on Corporate Progress and Third Quarter 2017 Financial Results

Cash, cash equivalents and marketable securities as of September 30, 2017, were $203.6 million, compared to $285.0 million as of December 31, 2016.

November 9, 2017
·
12 min read
Drug Development

IntelGenx Submits Montelukast VersaFilm Clinical Trial Application With Health Canada

IntelGenx announced that it has submitted a clinical trial application (“CTA”) to Health Canada for approval to initiate its Phase 2a proof of concept (“POC”) study with Montelukast in mild to moderate Alzheimer’s Disease (“AD”).

November 9, 2017
·
4 min read
Business

ContraFect Announces Third Quarter 2017 Financial Results

This quarter, ContraFect completed a public stock offering raising net proceeds of $37.1 million.

November 9, 2017
·
10 min read
Business

INC Research/inVentiv Health Reports Third Quarter 2017 Results

Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively.

November 9, 2017
·
31 min read